<DOC>
	<DOCNO>NCT02390479</DOCNO>
	<brief_summary>The primary objective case-control intervention study explore effectiveness non surgical periodontal therapy gingival crevicular fluid ( GCF ) level sclerostin patient chronic periodontitis ( CP ) get detailed insight diagnostic prognostic potential biomarker periodontal disease .</brief_summary>
	<brief_title>Gingival Crevicular Fluid Levels Sclerostin , Osteoprotegerin ( OPG ) RANKL Health , Disease After Treatment</brief_title>
	<detailed_description>All individual underwent full-mouth periodontal examination , include probe pocket depth ( PPD ) , clinical attachment level ( CAL ) , plaque index ( PI ) , gingival index ( GI ) , bleed probe ( BOP ) . Individuals categorize three group : individual clinically healthy periodontium ( group 1 ) , patient chronic periodontitis ( group 2 ) , group 3 consist patient chronic periodontitis ( group 2 ) , treat scale root planning . GCF sample grup 1 take baseline . In group 2 , GCF sample take non- surgical periodontal treatment . Sclerostin , OPG RANKL level determine use enzyme-linked immunosorbent assay .</detailed_description>
	<mesh_term>Periodontitis</mesh_term>
	<criteria>Criteria healthy group GI = 0 , PPD CAL ≤ 3 mm , sign attachment bone loss Criteria chronic periodontitis group clinical sign inflammation , red color swell gingival margin , GI ≥ 2 , PPD CAL ≥ 5 mm bone loss ( &gt; 30 % exist teeth ) Aggressive periodontitis , systemic disease ( i.e. , diabetes mellitus , cancer , human immunodeficiency virus , bonerelated disease compromise sclerostin , OPG RANKL level collagenmetabolic disease , disorder ) , chronic highdose steroid therapy , radiation immunosuppressive therapy , allergy sensitivity drug , pregnancy , lactation , current smoking , smoke within past 5 year . The individual history periodontal therapy drug therapy ( e.g . antiinflammatory , antibiotic treatment pharmacological treatment ) least six month .</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>49 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Sclerostin</keyword>
	<keyword>OPG</keyword>
	<keyword>RANKL</keyword>
</DOC>